The problem we solve: Diabetes makes patients more vulnerable to infection, both bacterial and viral. This is because an elevated blood glucose provides an environment for microorganisms to thrive and multiply. Not only that, but elevated blood glucose interrupts the ability of our white blood cells to fight infection.
About our solution: Diabetics can better maintain their blood sugar levels. Patients can be informed when symptoms of an infection occur. This leads to a lower risk of getting infected and reduces the severity of the disease in the event of an infection. diafyt determines the individual insulin demand of patients with type 1 diabetes using machine learning methods. An increase in insulin demand is an indicator of infection. In addition, data analysis detects an increase in body temperature. This allows us to identify the signs of coronavirus infection.Progress to date:
Diafyt is for type 1 diabetics, has TRL8, is a medical device, has CE mark for distribution in Europe, has been launched at Google Play store in DE, FR, ES, IT and UK. We would be able to build a COVID-19 enabled app in less than 3 month for US users and patients worldwide. However we are short of resources to build and ship as fast as needed.
Creator: Thomas Wuttke
Education: MSEE, LAW
Bio: we are a team! 1# Engineer, diabetic, founder (me) 2# Mathematics PhD 3# Medical doctor, PhD, Professor and clinical researcher 4# Engineer, PhD, university researcher 5# Manager for financials, sales and marketing
COVID Problem We Address
Fever is an indicator of COVID-19 infection. Regular fever measurement therefore helps to detect an infection early. A continuous measurement of the body temperature over 2 weeks can indicate a non-infection.
Our COVID Solution
The aim is to build a device that records body temperature over a longer period of time. A smartphone app can display the recorded data and make it available for further analysis.
No updates found .
Help us find best new ideas to fund by telling us what you think. Your feedback goes straight to the team behind this project in private, so tell them what you really think.